Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma

Neurology - United States
doi 10.1212/wnl.0b013e31820f2d94
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma

Neurology
Neurology
2014English

Primary Leptomeningeal Lymphoma: International Primary CNS Lymphoma Collaborative Group Report

Neurology
Neurology
2013English

Primary CNS Lymphoma- A Squash Diagnosis

Journal of Cytology & Histology
2011English

Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System Lymphoma

Archives of Ophthalmology
2008English

Emergence of Primary CNS Lymphoma in a Patient With Findings of CLIPPERS

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology
Hematology
2018English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Pembrolizumab Monotherapy in Patients With Primary Refractory Classical Hodgkin Lymphoma: Subgroup Analysis of the Phase 2 Keynote-087 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy